داء الانسداد الرئوي المزمن (COPD) هو ثالث سبب رئيسي للوفاة في العالم، وفق منظمة الصحة العالمية. وهو مرض رئوي التهابي مزمن يتسبب في انسداد تدفق الهواء من الرئتين. يقدم جون كوستيلو، دكتور الطب، طبيب الأدوية الرئوية في مايو كلينك للرعاية الصحية في لندن، نصائح للمصابين بداء الانسداد الرئوي المزمن حول طرق التنفس بشكل أسهل.
A doença pulmonar obstrutiva crônica (DPOC) é a terceira maior causa global de mortes, de acordo com a Organização Mundial da Saúde. John Costello, especialista em medicina pulmonar da Mayo Clinic Healthcare, em Londres, oferece dicas sobre como os pacientes de Covid podem respirar com mais conforto.
Researcher has determined that social support plays a significant role in tearing down tuberculosis (TB) treatment barriers and improving patient adherence to treatments.
Lung surgery patients who utilize a comprehensive, evidence-based enhanced recovery after surgery (ERAS) program require fewer opioid prescriptions when discharged and this effect was sustained over the 4-year study period.
The first study into the global impact of wildfire-related pollution and deaths comprehensively links short term exposure to wildfire-related fine particulate matters (PM2.5) in the air and all-cause, respiratory and cardiovascular mortalities across cities and regions around the globe.
COVID-19 infection does not appear to affect the lung function of young adults, according to new research presented at the ‘virtual’ European Respiratory Society International Congress today (Tuesday).
Losing weight and treating excess levels of fat in the blood may help prevent lung disease in firefighters exposed to dangerous levels of fine particles from fire, smoke, and toxic chemicals on Sept. 11, 2001, a new study shows.
The nationwide pulmonary fibrosis (PF) community will take a collective step forward to advance research, advocacy, and awareness in the Pulmonary Fibrosis Foundation's (PFF) National Walk Day on Saturday, Sept. 25, during Pulmonary Fibrosis Awareness Month.
Opening a new chapter in a long, storied history dating back to 1905, the American Thoracic Society is pleased to announce that it has completed a major rebrand which includes a new, elevated logo design and a refreshed mission statement asserting the Society’s leadership role in driving innovation in the respiratory space.
A researcher at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center received a five-year, $2.5 million grant from the National Cancer Institute to develop a novel therapy to treat lung cancer.
UC San Diego researchers developed first-of-their-kind lung organoids that include all cell types that make up the organ, allowing for “Phase 0” testing of new treatments for respiratory infections such as COVID-19.
A buildup of coronavirus in the lungs is likely behind the steep mortality rates seen in the pandemic, a new study finds. The results contrast with previous suspicions that simultaneous infections, such as bacterial pneumonia or overreaction of the body’s immune defense system, played major roles in heightened risk of death, the investigators say.
Drawing on SLAC facilities, Australian researchers have revealed how Streptococcus pneumoniae bacteria obtain manganese from our bodies, which could lead to better therapies to target the pathogen.
A new protocol for prone positioning — a technique commonly used to treat COVID-19 patients in respiratory distress by turning them on to their front to increase oxygen flow to the lungs, is published in the Journal of Frailty and Aging. Researchers from the University of Bristol (UK) in collaboration with clinicians at the Royal United Hospital in Bath (UK), conducted a literature review of the manoeuvre to develop a standard protocol for the adjuvant treatment that can be used for COVID-19 patients at high risk of dying being treated in normal hospital wards.
As COVID-19 hospitalizations once again soar in a fourth surge more than 18 months after the pandemic started, some patients continue to experience symptoms long after recovering from COVID, according to a Houston Methodist study recently published in Nature’s Scientific Reports.
Now that kids have gone back to day care, camp and school, at least some parts of life seem to be getting back to normal. But along with their crumpled-up artwork, kids are also bringing home germs. One virus in particular, respiratory syncytial virus (RSV), is causing concern while it circulates during what is typically its off-season. Here's what parents need to know about RSV, including how to differentiate it from COVID-19.
After more than 50 days on advanced life support, a multi-disciplinary team at UC San Diego Health helps a patient who contracted COVID-19 become a candidate for a successful double lung transplant. The transplant surgery was the first in the region performed on a COVID-19 patient.
A new pre-clinical study in rabbits finds breathing support with an end-expiratory pressure improves lung function in near-term newborns with elevated lung liquid volumes at birth. The study is published ahead of print in the Journal of Applied Physiology.
Researchers at Washington University School of Medicine in St. Louis have found that two populations of stem cells in the lung multiply during and after a viral respiratory infection, sometimes triggering a detrimental remodeling process that can cause persistent lung disease long after the virus has been cleared.
People who are HIV positive and living in high tuberculosis-transmission regions of the world are much more likely to finish a TB-prevention regimen lasting just three months – half as long as the standard treatment, a large clinical trial in Africa has found.
Illinois Gov. J.B. Pritzker signed into law a measure that requires hospitals and ambulatory surgery centers in the state to adopt policies to ensure surgical smoke plume elimination with an appropriate evacuation system.
A six country clinical study of more than 1,100 hospitalized COVID-19 patients who required high-flow nasal cannula oxygen therapy suggests that prone positioning (rotating patients with severe breathing issues so they are face down) soon after admission can significantly reduce the need for mechanical ventilation.
Beneficio de la rehabilitación pulmonar para la EPOC y otras afecciones del pulmón
尊敬的妙佑医疗国际(Mayo Clinic)：我的父亲罹患慢性阻塞性肺病多年，因病情恶化而住院治疗。医疗服务提供者建议我的父亲进行肺康复。他有点犹豫，不知道该如何是好。请问肺康复能为患有慢性阻塞性肺病的患者带来哪些好处？患有其他肺部疾病的人群您是否也建议肺康复？
السادة الأعزاء في مايو كلينك: والدي مصابٌ بداء الانسداد الرئوي المزمن منذ سنوات، إلا إنه أُدخِل إلى المستشفى بسبب تفاقم الأعراض المرتبطة بحالته. نصح مزود رعايته الصحية بضرورة بدء برنامج تأهيل رئوي. وهو متردد وغير متأكد بشأن ما يمكن توقعه. ما هي فوائد التأهيل الرئوي للمصابين بداء الانسداد الرئوي المزمن؟ هل توصون به للمصابين بحالات الرئة المَرضية الأخرى؟
Perguntas e respostas da Mayo Clinic: benefícios da reabilitação pulmonar para a doença pulmonar obstrutiva crônica e outras condições pulmonares
In a new article published in JNCI Cancer Spectrum, Moffitt Cancer Center researchers describe a prediction model they have created that includes information calculated from computed tomography images that can identify non-small cell lung cancer patients who are not likely to respond to immunotherapy.
A novel artificial intelligence blood testing technology developed by researchers at the Johns Hopkins Kimmel Cancer Center was found to detect over 90% of lung cancers in samples from nearly 800 individuals with and without cancer.
September is Pulmonary Fibrosis Awareness Month, presented by the Pulmonary Fibrosis Foundation (PFF) as a way to drive awareness of pulmonary fibrosis (PF), a debilitating, incurable lung disease. Learn more about the numerous endeavors intended to rejuvenate the fight against PF throughout September.
Expert Q&A: Do breakthrough cases mean we will soon need COVID boosters? The extremely contagious Delta variant continues to spread, prompting mask mandates, proof of vaccination, and other measures. Media invited to ask the experts about these and related topics.
Only 21 percent of patients with severe pneumonia caused by SARS-CoV-2 (the virus that causes COVID-19) have a documented bacterial superinfection at the time of intubation, resulting in potential overuse of antibiotics, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
An interdisciplinary team of researchers from McMaster and SickKids are developing a cutting-edge lung model that can better respond to viruses and drug treatments, giving scientists a tool to advance research in lung conditions like COVID-19, cystic fibrosis and allergens for asthma and air pollution.
A new study suggests that patients who contract COVID-19 and completely recover from all symptoms do not show evidence of lasting damage to the lungs. The multicenter observational study looked at COVID-19 survivors who experienced asymptomatic, moderate or severe COVID-19 infections and underwent an unrelated elective lung operation for lung nodules or lung cancer sometime after recovery.
Researchers in Moffitt Cancer Center’s Lung Cancer Center of Excellence believe a combination of checkpoint inhibitors with adoptive cell therapy could be the answer for non-small cell lung cancer patients. Results of their investigator-initiated phase 1 clinical trial evaluating the checkpoint inhibitor nivolumab in combination with tumor infiltrating lymphocyte (TIL) therapy was published today in Nature Medicine.
Increased air pollution in recent years has exacerbated health risks for people who suffer from pulmonary diseases and these dynamics underscore the importance of increasing the efficacy of drug delivery devices that administer active pharmaceutical ingredients to treat respiratory illnesses. In Physics of Fluids, researchers describe developing a computational evaluation of drug delivery through both pressurized metered-dose inhalers and dry powder inhalers to determine how the process can be improved.
The Red Tide Respiratory Forecast developed by the National Oceanic and Atmospheric Administration’s National Centers for Coastal Ocean Science (NOAA-NCCOS) in partnership with the Gulf of Mexico Coastal Ocean Observing System (GCOOS), the state of Florida and others, is now fully supported and available to the public.
The risk that both tobacco and electronic cigarettes can pose to regular smokers’ health has been well documented, but a new UCLA study illustrates just how quickly vaping can affect the cells of even healthy younger nonsmokers.
The ATS Research Program today announced two new grant opportunities made possible by the American Lung Association/ATS/CHEST Foundation Respiratory Health Equity Research Award. Each grant provides $100,000 in funding per year for two years.
A KAIST immunology research team found that a specific subtype of macrophages that originated from blood monocytes plays a key role in the hyper-inflammatory response in SARS-CoV-2 infected lungs, by performing single-cell RNA sequencing of bronchoalveolar lavage fluid cells.
In a proof-of-concept study, researchers at Children’s Hospital of Philadelphia (CHOP) have created a coating that can be applied to endotracheal tubes and release antimicrobial peptides that target infectious bacteria with specificity. The innovation could reduce upper-airway bacterial inflammation during intubation, a situation that can lead to chronic inflammation and a condition called subglottic stenosis, the narrowing of the airway by an accumulation of scar tissue. The findings were published recently in the journal The Laryngoscope.
Researchers have discovered a protein that may predict disease severity for scleroderma-associated interstitial lung disease, the leading cause of death for patients with the rare autoimmune condition. Higher circulating levels of the CTRP9 were associated with more severe lung disease, while low levels were associated with preserved function.
Scientists at Children’s Hospital of Philadelphia (CHOP) have identified two proteins that could be used for a potential vaccine against nontypeable Haemophilus influenzae (NTHi). Working in a mouse model, the investigators found that administering two bacterial adhesive proteins that play a key role in helping the bacteria to latch on to respiratory cells and initiate respiratory tract infection stimulated protective immunity against diverse NTHi strains, highlighting the vaccine potential.
NEWS STORIES IN THIS ISSUE: -Study: Race and Ethnicity May Impact Prevalence and Treatment of Heart Valve Dysfunction -Johns Hopkins Medicine Suggests Eliminating Nerve Cell Protein May Stop ALS, Dementia -Researchers Tell Doctors to Avoid Routine Urinary Tests for Older Patients with Delirium -Johns Hopkins Medicine Researchers Show How Air Pollution May Cause Chronic Sinusitis -Researchers ID Location on Brain Protein Linked to Parkinson’s Disease Development -COVID-19 News: The Return of Onsite Schooling — and How to Keep Your Kids Safe from COVID
Focus of the work is bolstering B-cell immunity to help body beat bacteria
The ATS Research Program and the American Lung Association have awarded Laurie Eldredge, MD, PhD, of the University of Washington/Seattle Children’s Hospital a $100,000 Partner Grant. The ATS Research Program Partner Grants provide crucial support to talented investigators from around the world, launching careers dedicated to scientific discovery and better patient care.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
